Citation Impact
Citing Papers
Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle
2008 Standout
Extensive Intrasubtype Recombination in South African Human Immunodeficiency Virus Type 1 Subtype C Infections
2007
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
A drug-controllable tag for visualizing newly synthesized proteins in cells and whole animals
2008 StandoutNobel
Novel therapeutic strategies targeting HIV integrase
2012
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Computational protein–ligand docking and virtual drug screening with the AutoDock suite
2016 Standout
Transmission of HIV-1 drug resistance
2004
Fragment‐Based Screen against HIV Protease
2010
Molecular Phylodynamics of the Heterosexual HIV Epidemic in the United Kingdom
2009
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients
2008
Simple diffusion-constrained immunoassay for p24 protein with the sensitivity of nucleic acid amplification for detecting acute HIV infection
2012
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo
2008
Syndemics and the biosocial conception of health
2017 Standout
Behaviors of Recently HIV-Infected Men Who Have Sex With Men in the Year Postdiagnosis: Effects of Drug Use and Partner Types
2010
Development of vaccines and antivirals for combating viral pandemics
2020 StandoutNobel
Factors Associated with the Emergence of K65R in Patients with HIV‐1 Infection Treated with Combination Antiretroviral Therapy Containing Tenofovir
2008
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Albumin–drug interaction and its clinical implication
2013 Standout
HIV-1 Transmission, by Stage of Infection
2008
Primary drug resistance and transmission analysis of HIV‐1 in acute and recent drug‐naïve seroconverters in Singapore
2009
Role of acute and early HIV infection in the sexual transmission of HIV
2010
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Laboratory Diagnosis of HIV in Adults: A Review of Current Methods
2013
HIV-1 treatment as prevention: the good, the bad, and the challenges
2011
No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa
2008
Characterization of resistance mutations against HCV ketoamide protease inhibitors
2008
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
2012 StandoutNobel
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics
2008
New developments in natural products‐based anti‐AIDS research
2006
Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection
2007
The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study
2011
Newly approved integrase inhibitors for clinical treatment of AIDS
2014
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy
2008
Myocarditis
2011 Standout
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
A new drug binding subsite on human serum albumin and drug–drug interaction studied by X-ray crystallography
2008
Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South Africa
2010
Global epidemiology of HIV
2009
Molecular Epidemiology Reveals Long‐Term Changes in HIV Type 1 Subtype B Transmission in Switzerland
2010
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Initiating Therapy: When to Start, What to Use
2008
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
SARS-CoV-2 variants, spike mutations and immune escape
2021 Standout
Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
2008
HIV diversity, molecular epidemiology, and the role of recombination
2005
Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel
2003
Rapid HIV screening: Missed opportunities for HIV diagnosis and prevention
2012
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
HIV Superinfection
2005
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis
2012 Standout
Elucidation of Hepatitis C Virus Transmission and Early Diversification by Single Genome Sequencing
2012
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco
2010
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Primary HIV Infection: Clinical Presentation, Testing, and Treatment
2017
Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034
2006
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world
2011
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis
2005 Standout
Interaction of Reverse Transcriptase (RT) Mutations Conferring Resistance to Lamivudine and Etravirine: Effects on Fitness and RT Activity of Human Immunodeficiency Virus Type 1
2011
Interpreting resistance data for HIV-1 therapy management--know the limitations.
2006
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Characterization and structural analysis of HIV-1 integrase conservation.
2009
AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings
2021 Standout
Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment
2008
DOCK 6: Impact of new features and current docking performance
2015
HIV Transmission
2012
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy
2010
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.
2009
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Human Immunodeficiency Virus Type 1 Subtype Distribution in the Worldwide Epidemic: Pathogenetic and Therapeutic Implications
2007
Mutation Rates and Intrinsic Fidelity of Retroviral Reverse Transcriptases
2009
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
2020 Standout
Neutral Theory and Rapidly Evolving Viral Pathogens
2018
UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1
2001 Standout
Transmission of drug-resistant HIV-1 in Europe remains limited to single classes
2008
Approved Antiviral Drugs over the Past 50 Years
2016
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
2020 Standout
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Understanding Basic Mechanisms and Optimizing Assays to Evaluate the Efficacy of Vaginal Microbicides
2009
Challenges and Advances in Validating Enzyme Design Proposals: The Case of Kemp Eliminase Catalysis
2011 StandoutNobel
Probability of a false-negative HIV antibody test result during the window period: a tool for pre- and post-test counselling
2014
Viral Quasispecies Evolution
2012
Intensified shigellosis epidemic associated with sexual transmission in men who have sex with men - Shigella flexneri and S. sonnei in England, 2004 to end of February 2015
2015
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-Acting Antiviral Agents
2014 StandoutNobel
2015 update of the drug resistance mutations in HIV-1
2015
RDP4: Detection and analysis of recombination patterns in virus genomes
2015 Standout
ARVs as HIV Prevention: A Tough Road to Wide Impact
2011 Science
Guidelines for the management of hemophilia
2012 Standout
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel
Topical microbicides and HIV prevention in the female genital tract
2014
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
Works of Daniela Moïsi being referenced
Subtype diversity associated with the development of HIV‐1 resistance to integrase inhibitors
2011
Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection
2004
Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline
2012
Transmission networks of drug resistance acquired in primary/early stage HIV infection
2008
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture
2006
A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors
2003
High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection
2007
Resistance mutations against dolutegravir in HIV integrase impair the emergence of resistance against reverse transcriptase inhibitors
2014
Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT
2002
Nucleotide and Amino Acid Polymorphisms at Drug Resistance Sites in Non-B-Subtype Variants of Human Immunodeficiency Virus Type 1
2004
Natural Polymorphisms in the Human Immunodeficiency Virus Type 2 Protease Can Accelerate Time to Development of Resistance to Protease Inhibitors
2006
Detection of Human Immunodeficiency Virus (HIV) Type 1 M184V and K103N Minority Variants in Patients with Primary HIV Infection
2009
The M184V Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Delays the Development of Resistance to Amprenavir and Efavirenz in Subtype B and C Clinical Isolates
2003
Differential Maintenance of the M184V Substitution in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 by Various Nucleoside Antiretroviral Agents in Tissue Culture
2004
Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection
2002
Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection
2004
Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec
2011
Pressure of Zidovudine Accelerates the Reversion of Lamivudine Resistance-Conferring M184V Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1
2002
Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes
2010
Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zidovudine
2007
In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug Dapivirine
2011